Natco Pharma rises 4% after filing ANDA for generic lung cancer drug



Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug

Natco Pharma rises 4% after filing ANDA for generic lung cancer drug
Natco Pharma rises 4% after filing ANDA for generic lung cancer drug
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Ecos Mobility IPO gets subscribed over 64 times on offer's closing day
Baazar Style Retail IPO receives 72% subscription on day 1 of offer

Rakesh Gangwal, family trust sells 5.83% stake in IndiGo for Rs 10,500 cr
IFSCA releases final norms for Gift City listings, sets IPO eligibility